Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2022

Balance Sheet Components Disclosure [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 31,
	2022		2021
Accrued research and development expenses	$	7,449	$	3,837
Accrued compensation and benefits		1,286		1,435
Accrued general and administrative expenses		525		416
Operating lease liability, current portion		139		360
Total accrued expenses and other current liabilities	$	9,399	$	6,048